A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder

Clinical trial NCT01685151 · WITHDRAWN

Trial details

NCT number: NCT01685151
Sponsor: Takeda
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2012-09-01
Primary completion: 2015-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.